best large cap oct 2022 to 1 jan 2023

Madrigal Pharmaceuticals (MDGL) had the highest return between October 1, 2022 and January 1, 2023 by a large-cap US stock, returning 336.6%.

ASSETDATE% RETURN
Madrigal Pharmaceuticals (MDGL)
10/1/2022 - 1/1/2023
336.6%
Summit Therapeutics (SMMT)
10/1/2022 - 1/1/2023
254.17%
Roivant Sciences (ROIV)
10/1/2022 - 1/1/2023
151.26%
Tencent Music Entertainment (TME)
10/1/2022 - 1/1/2023
105.97%
Burlington Stores (BURL)
10/1/2022 - 1/1/2023
79.21%
BeiGene (ONC)
10/1/2022 - 1/1/2023
65.1%
Universal Health Services (UHS)
10/1/2022 - 1/1/2023
57.57%
Deutsche Bank (DB)
10/1/2022 - 1/1/2023
56.52%
Boeing (BA)
10/1/2022 - 1/1/2023
56.14%
Bilibili (BILI)
10/1/2022 - 1/1/2023
53.53%
Halliburton (HAL)
10/1/2022 - 1/1/2023
51.91%
EXACT Sciences (EXAS)
10/1/2022 - 1/1/2023
50.9%
Warner Music (WMG)
10/1/2022 - 1/1/2023
50.86%
Moderna (MRNA)
10/1/2022 - 1/1/2023
50.54%
POSCO (PKX)
10/1/2022 - 1/1/2023
47.5%
Mitsubishi UFJ Financial Group Inc ADR (MUFG)
10/1/2022 - 1/1/2023
46.92%
Super Micro Computer (SMCI)
10/1/2022 - 1/1/2023
45.18%
Sumitomo Mitsui Financial (SMFG)
10/1/2022 - 1/1/2023
44.5%
Fair Isaac (FICO)
10/1/2022 - 1/1/2023
44.18%
Caterpillar (CAT)
10/1/2022 - 1/1/2023
44.04%
Axon Enterprise (AXON)
10/1/2022 - 1/1/2023
42.93%
Schlumberger (SLB)
10/1/2022 - 1/1/2023
42.74%
ING Group NV ADR (ING)
10/1/2022 - 1/1/2023
42.01%
YPF Sociedad Anonima (YPF)
10/1/2022 - 1/1/2023
41.38%
Nike (NKE)
10/1/2022 - 1/1/2023
41.19%
Large-cap stocks are treated as having a market cap of $10B+.